Search Results 411-420 of 18665 for crohn's disease

  1. Infliximab-dyyb (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Infliximab-dyyb injection is used to reduce the symptoms of moderate to severe active Crohn's disease and ulcerative colitis in adults and children who have ...

  2. Publications - Jonathan A. Leighton, M.D. - Mayo Clinic

    Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer. ... Crohn's disease: economic impact of disease diagnosis ...

  3. Ulcerative colitis - Doctors and departments - Mayo Clinic

    This type of inflammatory bowel disease affects the innermost lining of your digestive tract. Learn about available treatments for this often exhausting ...

  4. Jana G. Al Hashash, M.D., M.S. - Doctors and Medical Staff - Mayo Clinic

    ... inflammatory bowel diseases (IBD), which include patients with Crohn's disease and ulcerative colitis. Prior to joining the Inflammatory Bowel Disease ...

  5. CT Enterography Clinical Trials - Mayo Clinic Research

    Low-dose CT Enterography for Pediatric Crohn's Disease Diagnosis and Staging Rochester, MN. The study will estimate observer performance for Low-dose CT ...

  6. Examining the efficacy of recombinant zoster vaccination in patients with IBD - Mayo Clinic

    Individuals diagnosed with inflammatory bowel disease (IBD) have an increased risk of developing herpes zoster (HZ) and HZ-related complications.

  7. Laura E. Raffals, M.D. - Doctors and Medical Staff - Mayo Clinic

    Inflammatory bowel disease (Crohn's disease and ulcerative colitis); Pouchitis; Role of the microbiota in inflammatory bowel disease ...

  8. A Study to Evaluate the Effectiveness and Safety of Oral OPS-2071 in Subjects With Crohn's Disease Showing Symptoms of Active Inflammation - Mayo Clinic

    The purpose of this study is to evaluate the effects, safety and how OPS-2071 (150, 300, or 600 mg twice a day [BID]) is as an add-on therapy in Crohn's disease ...

  9. Publications - Michael C. Stephens, M.D. - Mayo Clinic

    Safety and steroid-sparing experience using infliximab for Crohn's disease at a pediatric inflammatory bowel disease center. Am J Gastroenterol. 2003 Jan ...

  10. A Study of the Safety and Effectiveness of GS-5745 in Participants with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate the safety and efficacy of GS-5745 in adults with active Crohn's disease. The study will consist of a Blinded ...